Clay Crolius
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Clay Crolius
Clay Crolius is recorded as CFO at DNA X, Inc. (SONM). DNA X, Inc. reported in an 8-K filed July 13, 2022 that Clay Crolius was appointed Chief Financial Officer (principal financial and accounting officer), effective July 13, 2022. The proxy statement of DNA X, Inc. reports total compensation of $503,021 for Clay Crolius in fiscal 2024, including a base salary of $320,000. Disclosed compensation is on record for 4 fiscal years.
“On July 13, 2022, following the first closing, the Board appointed Clay Crolius as Chief Financial Officer (principal financial and accounting officer) of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at DNA X, Inc.
Other people whose current roles at this company are on record from its filings.
- Mike Mulica CEO, Board Member
- Peter Hao Liu CEO, Board Member
- Robert Plaschke CEO
- Thomas W. Wilkinson CEO
- Jeffrey Wang Chairman, Board Member
- Michael Mulica Chairman, Board Member
- James Walker CFO
- George Thangadurai Board Member
- Jack Steenstra Board Member
- James Cassano Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | DNA X, Inc. (SONM) | Chief Financial Officer | $320,000 | $503,021 |
| 2023 | DNA X, Inc. (SONM) | Chief Financial Officer | $323,750 | $577,270 |
| 2022 | DNA X, Inc. (SONM) | Chief Financial Officer | $129,343 | $384,913 |
| 2021 | DNA X, Inc. (SONM) | Chief Financial Officer | — | $124,640 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.